Results 161 to 170 of about 4,224,464 (309)

Editorial Board

open access: yesNursing & Health Sciences Research Journal, 2021
Nursing & Health Sciences Research Journal
doaj  

Information Interface - Volume 33, Issue 2 - May/June 2005

open access: yes, 2005
News and information about Himmelfarb Health Sciences Library of interest to users.
George Washington University, Himmelfarb Health Sciences Library
core  

Dammarenediol II enhances etoposide‐induced apoptosis by targeting O‐GlcNAc transferase and Akt/GSK3β/mTOR signaling in liver cancer

open access: yesMolecular Oncology, Volume 20, Issue 6, Page 1591-1611, June 2026.
Etoposide induces DNA damage, activating p53‐dependent apoptosis via caspase‐3/7, which cleaves PARP1. Dammarenediol II enhances this apoptotic pathway by suppressing O‐GlcNAc transferase activity, further decreasing O‐GlcNAcylation. The reduction in O‐GlcNAc levels boosts p53‐driven apoptosis and influences the Akt/GSK3β/mTOR signaling pathway ...
Jaehoon Lee   +8 more
wiley   +1 more source

Presentations of Sultan Qaboos University Clinico-Pathologic Conferences

open access: yesSultan Qaboos University Medical Journal, 2015
Sultan Qaboos University College of Medicine & Health Sciences and Sultan Qaboos University Hospital, 2014–2015
doaj   +1 more source

Information Interface - Volume 30, Issue 2 - March/April 2002

open access: yes, 2002
News and information about Himmelfarb Health Sciences Library of interest to ...
George Washington University, Himmelfarb Health Sciences Library
core  

TRAIL‐PEG‐Apt‐PLGA nanosystem as an aptamer‐targeted drug delivery system potential for triple‐negative breast cancer therapy using in vivo mouse model

open access: yesMolecular Oncology, EarlyView.
Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy